MINISTERIAL ORDER N° 001/MoH/2021 OF 12/05/2021 DETERMINING BLOOD COMPONENTS WHICH MAY BE SOLD AND THE APPLICABLE PROCEDURE THEREOF | 001/MOH/2021 OF 12/05/2021 — Rwanda law | Esheria

MINISTERIAL ORDER N° 001/MoH/2021 OF 12/05/2021 DETERMINING BLOOD COMPONENTS WHICH MAY BE SOLD AND THE APPLICABLE PROCEDURE THEREOF

This Order sets out which blood components may be sold and the procedure for selling them.

AI-assisted research synopsis — verify against the official legal text below.

Jurisdiction
Rwanda
Instrument
Order
Citation
001/MOH/2021 OF 12/05/2021
Status
In force
Version
Undated source snapshot
Language
mul
Updated
Official source
View official record ↗
blood components blood products export authorization medical manufacturing plasma plasma collection plasma sale plasma sales plasma trade plasma transaction pricing product quality repeal reporting sale sale procedure selling procedure

Statute overview

About this statute

This Order sets out which blood components may be sold and the procedure for selling them. This article defines key terms used in the Order, including blood components, plasma, plasma fractionator, the Minister, and the Institution. Plasma is the blood component to be sold. The authority in charge of regulating biological products sets the quality requirements for plasma sold in the market. A plasma fractionator must write to the Institution to express interest in buying plasma, and the Institution must assess the request and accept or reject it.